The antitumor effect of trabectedin (TR) is potentiated by olaparib (OL) in preclinical models of bone and soft tissue sarcomas (STS).

被引：0

作者：

Pignochino, Ymera ^{[1
]}

Capozzi, Federica ^{[2
]}

Dell'aglio, Carmine ^{[2
]}

Basirico, Marco ^{[2
]}

D'ambrosio, Lorenzo ^{[2
]}

Galizia, Danilo ^{[2
]}

Palesandro, Erica ^{[2
]}

Benassi, Maria Serena ^{[3
]}

Aglietta, Massimo ^{[2
]}

Grignani, Giovanni ^{[4
]}

机构：

[1] Univ Turin, Fdn Piemonte Oncol, Candiolo, Italy

[2] Univ Turin, Candiolo, Italy

[3] Ist Ortoped Rizzoli, Bologna, Italy

[4] FPO, Candiolo, Italy

来源：

CANCER RESEARCH | 2013年 / 73卷 / 08期

关键词：

D O I：

10.1158/1538-7445.AM2013-LB-213

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB213

引用

页数：1

共 50 条

[31] Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc).
Reichardt, Peter
Andreou, Dimosthenis
Floercken, Anne
Gross, Thorben
Richter, Stephan
Kessler, Torsten
Kortuem, Martin
Schmidt, Christian Andreas
Kasper, Bernd
Wardelmann, Eva
Benedict, Atzler
Sookthai, Disorn
Mueller, Daniel Wilhelm
Pink, Daniel
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[32] CUL4A and ERCC1 genesas predictive factors for trabectedin efficacy in advanced soft tissue sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) study.
Broto, Javier Martin
Fernandez-Serra, Antonio
Lopez-Pousa, Antonio
Gutierrez, Antonio
De Las Penas, Ramon
Martinez-Trufero, Javier
Cruz, Josefina
Alvarez, Rosa Maria
Cubedo, Ricardo
Redondo, Andres
Carrasco, Juan Antonio
Lopez-Martin, Jose A.
Sala, Maria Angeles
Sevilla, Isabel
Balana, Carmen
Salgado, Maria Angeles Vaz
De Juan, Ana
Poveda, Andres
Hindi, Nadia
Lopez-Guerrero, Jose Antonio
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[33] Analysis of Hohn (HC) and porth-a-cath (PAC) central venous catheters (CVC) adverse events (AEs) and related costs in advanced soft tissue sarcomas (STS) treated with trabectedin (TR) 24-hour (24-h) infusion therapy
Palesandro, Erica
Boccone, Paola
D'Ambrosio, Lorenzo
Galizia, Danilo
Aliberti, Sandra
Debernardi, Felicino
Bona, Francesco
Manca, Antonio
Anselmetti, Giovanni Carlo
Russo, Filippo
Campanella, Delia
Aglietta, Massimo
Grignani, Giovanni
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[34] S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models
Pantano, F.
Simonetti, S.
Iuliani, M.
Guillen, M. J.
Cuevas, C.
Aviles, P.
Cavaliere, S.
Napolitano, A.
Cortellini, A.
Mazzocca, A.
Nibid, L.
Sabarese, G.
Perrone, G.
Gambarotti, M.
Righi, A.
Palmerini, E.
Stacchiotti, S.
Barisella, M.
Gronchi, A.
Valeri, S.
Sbaraglia, M.
Dei Tos, A. P.
Tonini, G.
Vincenzi, B.
ONCOGENE, 2024, 43 (40) : 2986 - 2994
[35] XenoSarc: Patient-derived xenograft (PDX) models of soft tissue sarcoma (STS)-an update on a preclinical platform for early drug testing
Wozniak, Agnieszka
Cornillie, Jasmien
Gebreyohannes, Yemarshet K.
Wang, Yannick
Wellens, Jasmien
Vanleeuw, Ulla
Hompes, Daphne
Stas, Marguerite
Sinnaeve, Friedl
Wafa, Hazem
Debiec-Rychter, Maria
Sciot, Raf
Schoffski, Patrick
CANCER RESEARCH, 2018, 78 (13)
[36] XenoSarc: Patient-derived xenograft (PDX) models of soft tissue sarcoma (STS), an update on a preclinical platform for early drug testing
Wozniak, Agnieszka
Cornillie, Jasmien
Gebreyohannes, Yemarshet K.
Wellens, Jasmien
Vreys, Lise
Hompes, Daphne
Stas, Marguerite
Sinnaeve, Friedl
Debiec-Rychter, Maria
Sciot, Raf
Schoffski, Patrick
CANCER RESEARCH, 2017, 77
[37] Preclinical evaluation of radiotherapy in combination with radio-sensitizing telomerase-specific oncolytic virus for human bone and soft tissue sarcomas
Omori, Toshinori
Yamakawa, Yasuaki
Hasei, Joe
Tazawa, Hiroshi
Osaki, Shuhei
Sasaki, Tusyoshi
Sugiu, Kazuhisa
Fujiwara, Tomohiro
Kunisada, Toshiyuki
Urata, Yasuo
Ozaki, Toshifumi
Fujiwara, Toshiyoshi
CANCER RESEARCH, 2015, 75
[38] The First-In-Class Anti-AXLxCD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas
Polera, Nicoletta
Mancuso, Antonia
Riillo, Caterina
Caracciolo, Daniele
Signorelli, Stefania
Grillone, Katia
Ascrizzi, Serena
Hokanson, Craig A.
Conforti, Francesco
Staropoli, Nicoletta
Gervasi, Luigia
Di Martino, Maria Teresa
Arbitrio, Mariamena
Nistico, Giuseppe
Crea, Roberto
Tagliaferri, Pierosandro
Juli, Giada
Tassone, Pierfrancesco
CANCERS, 2023, 15 (06)
[39] CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study
Moura, David S.
Sanchez-Bustos, Paloma
Fernandez-Serra, Antonio
Lopez-Alvarez, Maria
Mondaza-Hernandez, Jose L.
Blanco-Alcaina, Elena
Gavilan-Naranjo, Angela
Martinez-Delgado, Paula
Lacerenza, Serena
Santos-Fernandez, Paloma
Carrasco-Garcia, Irene
Hidalgo-Rios, Samuel
Gutierrez, Antonio
Ramos, Rafael
Hindi, Nadia
Taron, Miguel
Antonio Lopez-Guerrero, Jose
Martin-Broto, Javier
CANCERS, 2020, 12 (05)
[40] Growth rate and site of pulmonary metastasis to predict lung relapse and overall survival in patients affected by bone and soft tissue sarcomas (B-STS).
D'ambrosio, Lorenzo
Tolomeo, Francesco
Bruna, Maria Cristina
Aliberti, Sandra
Merlini, Alessandra
Manessi, Giulia
Mogavero, Andrea
Minelli, Alessandro
Robba, Tiziana
Campanella, Delia
Pisacane, Alberto
Maldi, Elena
Piana, Raimondo
Ruffini, Enrico
Mossetti, Claudio
Vincenzi, Bruno
Grignani, Giovanni
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 3 4 5 →